--- title: What is Myopia? - Eyerising International description: What is myopia? Learn about short-sightedness, why prevalence is rising globally, the risks of high myopia, and current management options including RLRL therapy. image: https://eyerisinginternational.com/hubfs/eri-web/images/og-default.png --- I am not an eye-care professional I am an eye-care professional Viewing the International site. [![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png)](https://eyerisinginternational.com/?hsLang=en) [Home](https://eyerisinginternational.com/?hsLang=en) [About Us](https://eyerisinginternational.com/about?hsLang=en) [About Eyerising](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory](https://eyerisinginternational.com/regulatory?hsLang=en) [News](https://eyerisinginternational.com/news?hsLang=en) [Latest News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) [Events](https://eyerisinginternational.com/events?hsLang=en) [Contact](https://eyerisinginternational.com/contact?hsLang=en) [Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) [Get in Touch](https://eyerisinginternational.com/contact?hsLang=en) [Home](https://eyerisinginternational.com/?hsLang=en) [About Us](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en) [News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) [Events](https://eyerisinginternational.com/events?hsLang=en) [Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) [Get in Touch](https://eyerisinginternational.com/contact?hsLang=en) # Not Available in Your Region This page is not available to visitors in Australia. [Return to Homepage](https://eyerisinginternational.com/?hsLang=en) # What is Myopia? Understanding short-sightedness and why early management matters. ## Understanding Myopia Myopia (short-sightedness) is a common refractive condition where distant objects appear blurred. Prevalence has been increasing worldwide, particularly in parts of East Asia, and it is recognised as an important public health concern. While many children develop mild myopia, higher levels are associated with increased risk of retinal detachment, glaucoma, and myopic maculopathy later in life.1 Managing myopia progression in childhood can help reduce the likelihood of developing higher levels of myopia and associated complications. By 2050, an estimated **50% of the world's population** will be affected by myopia, with **almost 10%** having high myopia.2 ![About Myopia - understanding short-sightedness](https://eyerisinginternational.com/hubfs/eri-web/images/about-myopia.jpg) ## Why Early Management Matters High myopia significantly increases the risk of serious eye conditions later in life. Early intervention is critical to protecting long-term vision health. ### Retinal Detachment High myopia stretches and thins the retina, significantly increasing the risk of retinal tears and detachment, a sight-threatening emergency. ### Glaucoma People with high myopia have a two to three times greater risk of developing glaucoma, a progressive condition that can lead to permanent vision loss. ### Myopic Maculopathy Degeneration of the macula caused by axial elongation of the eye. One of the leading causes of irreversible blindness in high myopes. ### Cataracts High myopia is associated with earlier onset of cataracts, increasing the likelihood of requiring surgical intervention at a younger age. ## There is No Single Solution Myopia management is an evolving field. Current strategies supported by published evidence include specially designed spectacle lenses, contact lenses, low-dose atropine eye drops, and RLRL therapy. Each approach has its advantages and limitations. ### Spectacle Lenses Specially designed myopia control spectacle lenses, such as defocus-incorporated lenses, can help slow axial elongation compared to standard single-vision lenses. ### Contact Lenses Orthokeratology and soft multifocal contact lenses are used to temporarily reshape the cornea or modify peripheral defocus to reduce myopia progression. ### Atropine Eye Drops Low-dose atropine has demonstrated efficacy in slowing myopia progression. Requires ongoing clinical supervision and monitoring for side effects. ### RLRL Therapy Eyerising Repeated Low-Level Red-Light therapy is a non-invasive, non-contact treatment delivered via a handheld device. Clinical studies have shown significant reductions in axial elongation with a strong safety profile. ## An Evidence-Based Option Eyerising International has developed the Eyerising Myopia Management Device, which delivers RLRL therapy for children aged 3–16 years old. Published clinical studies have reported reductions in axial elongation and slowing of myopia progression, with some studies reporting effects of up to **87.7%** compared to control groups.3 The device is designed for home use under professional supervision, with a protocol of 3-minute sessions, twice daily, 5 days per week, with a minimum of 4 hours between sessions. The Eyerising Myopia Management Device is available exclusively through optometrists and ophthalmologists. Outcomes may vary for each patient. [Learn About the Device](https://eyerisinginternational.com/device?hsLang=en) 1 Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739–1748. 2 Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006. 3 Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, Xiong R, Yuan Y, Zeng J, Morgan IG, He M. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2022;129(5):509-19. ![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png) Advancing myopia management through repeated low-level red-light therapy. #### Company - [About Us](https://eyerisinginternational.com/about?hsLang=en) - [Our Team](https://eyerisinginternational.com/team?hsLang=en) - [Our Story](https://eyerisinginternational.com/story?hsLang=en) - [News](https://eyerisinginternational.com/news?hsLang=en) - [Events](https://eyerisinginternational.com/events?hsLang=en) #### Resources - [Our Device](https://eyerisinginternational.com/device?hsLang=en) - [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) - [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en) - [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) - [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) #### Contact Suite 2.05, 9/11 Claremont St South Yarra VIC 3141, Australia [info@eyerisinginternational.com](mailto:info@eyerisinginternational.com) [LinkedIn](https://au.linkedin.com/company/eyerising-international) THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE Ask your optometrist or ophthalmologist for advice to see if this product is right for your child. Outcomes may vary for each patient. The Eyerising Myopia Management Device is exclusively available through eye care professionals (e.g. optometrists, ophthalmologists) for home use. © 2026 Eyerising International. All rights reserved. [LinkedIn](https://au.linkedin.com/company/eyerising-international) [Privacy Policy](https://eyerisinginternational.com/legal?hsLang=en) [Terms & Conditions](https://eyerisinginternational.com/legal?hsLang=en) ## Welcome to Eyerising International To show you the most relevant information, please confirm which best describes you. I am not an Eye-Care Professional I am an Eye-Care Professional ## Disclaimer This website is intended for use by eye care professionals only. By agreeing and proceeding, you are declaring you are a registered eye care professional. If you are not a registered eye care professional, do not proceed. I Agree I Disagree ```json { "@context" : "https://schema.org", "@type" : "MedicalOrganization", "address" : { "@type" : "PostalAddress", "addressCountry" : "AU", "addressLocality" : "South Yarra", "addressRegion" : "VIC", "postalCode" : "3141", "streetAddress" : "Suite 2.05, 9/11 Claremont St" }, "contactPoint" : { "@type" : "ContactPoint", "contactType" : "customer service", "email" : "info@eyerisinginternational.com" }, "description" : "Australian MedTech company advancing repeated low-level red-light (RLRL) therapy for childhood myopia management.", "foundingDate" : "2020", "logo" : "https://43619611.fs1.hubspotusercontent-ap1.net/hubfs/43619611/eri-web/logo-white.png", "name" : "Eyerising International", "sameAs" : [ "https://www.linkedin.com/company/eyerising-international" ], "url" : "https://eyerisinginternational.com" } ```